Semaglutide in spinal cord injury and diabetic subjects
Lay Description
This study well measure the effectiveness of semaglutide on insulin sensitivity, body weight and fat/lean mass in subjects spinal cord injuries and diabetes
Category
- Diabetes
- IRB Number
- STUDY00000591
- NCT Number
- NCT06706284
Eligibility
- Eligible Ages
- 18-70
- Eligible Genders
- all
- Accepts Healthy Volunteers
- No
Inclusion Criteria
spinal cord injury (greater than 1 year post SCI)
type 2 diabetes (BMI >22kg/m2)
Exclusion Criteria
older than 70
pregnant
Study Design
Arm Groups
Study Contact
Nancy Yegge
210-450-8696
YEGGEN@UTHSCSA.EDU
Azam Alamdari
448-500-5693
alamdari@uthscsa.edu
Jennifer Foster
210-567-5925
fosterj6@uthscsa.edu
Andrea Hansis-Diarte
210-567-3208
hansisdiarte@uthscsa.edu
Jennifer Foster
210-567-5925
fosterj6@uthscsa.edu
Azam Alamdari
448-500-5693
alamdari@uthscsa.edu
Principal Investigator
Marzieh Salehi